Repeatable prescription validity — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — The two products cannot be supplied together in one transaction; assess which single product, if any, is suitable
UK restrictions prohibit selling or supplying a pseudoephedrine-containing product and an ephedrine-containing product in the same transaction, even when each amount is below its separate 720 mg and 180 mg maximum. Dividing one purchase into two till receipts or obtaining a customer declaration does not remove the restriction. The pharmacist should assess symptoms and misuse risk, then decide whether one suitable product can be supplied.
Reference: MHRA: pseudoephedrine and ephedrine — managing risk of misuse. https://www.gov.uk/drug-safety-update/pseudoephedrine-and-ephedrine-managing-risk-of-misuse